Fibrosing interstitial lung disease - Treatment with a cytotoxic agent Factor
Last reviewed for CCPS 16 December 2009.
Preliminary questions [40669]
40688 there is some evidence that treatment with a cytotoxic agent may be a factor in the development or worsening of the condition under consideration.
40962 the veteran has been treated with a cytotoxic agent at some time.
40963 the veteran was treated with a cytotoxic agent for a malignant disease or in association with haematopoietic stem cell transplantation.
40964 — the treatment with a cytotoxic agent was for treatment of an illness or injury which is identifiable.
40967 — the veteran has established the causal connection between treatment with a cytotoxic agent and VEA service for fibrosing interstitial lung disease.
for treatment of the identified illness or injury, the veteran was treated with a cytotoxic agent before the clinical onset of fibrosing interstitial lung disease.40968 — the veteran has established the causal connection between treatment with a cytotoxic agent and VEA service for the clinical onset of fibrosing interstitial lung disease.
40970 — the veteran has established the causal connection between treatment with a cytotoxic agent and operational service for the clinical onset of fibrosing interstitial lung disease.
or
40971 — the veteran has established the causal connection between treatment with a cytotoxic agent and eligible service for the clinical onset of fibrosing interstitial lung disease.
or
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened. for treatment of the identified illness or injury, the veteran was treated with a cytotoxic agent before the clinical worsening of fibrosing interstitial lung disease.40969 — the veteran has established the causal connection between treatment with a cytotoxic agent and VEA service for the clinical worsening of fibrosing interstitial lung disease.
40972 — the veteran has established the causal connection between treatment with a cytotoxic agent and operational service for the clinical worsening of fibrosing interstitial lung disease.
or
40973 — the veteran has established the causal connection between treatment with a cytotoxic agent and eligible service for the clinical worsening of fibrosing interstitial lung disease.
Clinical onset and operational service [40970]
40974 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to operational service.
Clinical onset and eligible service [40971]
40975 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to eligible service.
Clinical worsening and operational service [40972]
40974 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related.Clinical worsening and eligible service [40973]
40975 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to eligible service.
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related.